https://kalkine.com/news/healthcare/cvs-spent-two-decades-building-an-empire-now-its-taking-it-apart Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 CVS Spent Two Decades Building an Empire. Now It’s Taking It Apart NYSE:CVS Healthcare https://kalkine.com/featured_image/gallery/large/shutterstock_1967461081_11_13_2026_20_31_55_902403.jpg CVS Spent Two Decades Building an Empire. Now It’s Taking It Apart https://kalkine.com/news/general-news/nvidia-nasdaqnvda-ceo-search-weighs-insiders-and-outside-executives Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Nvidia (NASDAQ:NVDA) CEO Search Weighs Insiders and Outside Executives NASDAQ:NVDA General News https://kalkine.com/featured_image/gallery/large/shutterstock_2293061599_11_13_2026_20_31_22_949710.jpg Nvidia (NASDAQ:NVDA) CEO Search Weighs Insiders and Outside Executives https://kalkine.com/news/general-news/israels-opposition-leader-gets-the-first-mandate-but-coalition-math-remains-hard Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Israel's Opposition Leader Gets the First Mandate, but Coalition Math Remains Hard General News https://kalkine.com/featured_image/gallery/large/shutterstock_2361634029_11_13_2026_20_30_49_995896.jpg Israel's Opposition Leader Gets the First Mandate, but Coalition Math Remains Hard https://kalkine.com/news/general-news/alphabet-nasdaqgoogl-faces-search-monetization-questions-as-ai-mode-grows Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Alphabet (NASDAQ:GOOGL) Faces Search Monetization Questions as AI Mode Grows NASDAQ:GOOGL General News https://kalkine.com/featured_image/gallery/large/shutterstock_2387819883_11_13_2026_20_31_14_011211.jpg Alphabet (NASDAQ:GOOGL) Faces Search Monetization Questions as AI Mode Grows https://kalkine.com/news/general-news/nvidia-nasdaqnvda-faces-culture-china-and-export-control-questions-after-huangs-exit Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Nvidia (NASDAQ:NVDA) Faces Culture, China and Export-Control Questions After Huang's Exit NASDAQ:NVDA General News https://kalkine.com/featured_image/gallery/large/shutterstock_421309492_11_13_2026_20_31_46_035427.jpg Nvidia (NASDAQ:NVDA) Faces Culture, China and Export-Control Questions After Huang's Exit https://kalkine.com/education/retirement-planning/401k-vs-ira-in-2027-a-beginners-guide-to-contribution-limits Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 401(k) vs IRA in 2027: A Beginner's Guide to Contribution Limits Retirement Planning https://kalkine.com/featured_image/gallery/large/shutterstock_2038929899_11_13_2026_20_31_51_034263.jpg 401(k) vs IRA in 2027: A Beginner's Guide to Contribution Limits https://kalkine.com/news/general-news/fed-to-cut-rate-setting-meetings-from-2027-raising-the-stakes-for-warshs-communications Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Fed to Cut Rate-Setting Meetings From 2027, Raising the Stakes for Warsh's Communications General News https://kalkine.com/featured_image/gallery/large/shutterstock_477783301_11_13_2026_20_31_32_155414.jpg Fed to Cut Rate-Setting Meetings From 2027, Raising the Stakes for Warsh's Communications https://kalkine.com/news/general-news/trump-faces-a-post-midterm-choice-between-deals-with-democrats-and-digging-in Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Trump Faces a Post-Midterm Choice Between Deals With Democrats and Digging In General News https://kalkine.com/featured_image/gallery/large/F30(5)_11_13_2026_20_30_45_840725.jpg Trump Faces a Post-Midterm Choice Between Deals With Democrats and Digging In https://kalkine.com/news/general-news/indian-stocks-outperform-asia-as-investors-rotate-out-of-ai-hardware Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Indian Stocks Outperform Asia as Investors Rotate Out of AI Hardware General News https://kalkine.com/featured_image/gallery/large/shutterstock_2515069555_11_13_2026_20_30_55_293501.jpg Indian Stocks Outperform Asia as Investors Rotate Out of AI Hardware https://kalkine.com/education/retirement-planning/2027-401k-limit-rises-to-25500-how-much-can-workers-save-next-year Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 2027 401(k) Limit Rises to $25,500: How Much Can Workers Save Next Year? Retirement Planning https://kalkine.com/featured_image/gallery/large/shutterstock_2337393415_11_13_2026_20_32_01_321364.jpg 2027 401(k) Limit Rises to $25,500: How Much Can Workers Save Next Year? https://kalkine.com/news/general-news/nvidia-nasdaqnvda-holds-usd-48-billion-in-private-stakes-as-its-founder-exits Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Nvidia (NASDAQ:NVDA) Holds USD 48 Billion in Private Stakes as Its Founder Exits NASDAQ:NVDA General News https://kalkine.com/featured_image/gallery/large/shutterstock_2462071287_11_13_2026_20_31_27_485161.jpg Nvidia (NASDAQ:NVDA) Holds USD 48 Billion in Private Stakes as Its Founder Exits https://kalkine.com/news/general-news/lightly-tariffed-ai-hardware-drives-trade-growth-and-record-us-imports Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Lightly Tariffed AI Hardware Drives Trade Growth and Record US Imports General News https://kalkine.com/featured_image/gallery/large/shutterstock_2700934625_11_13_2026_20_31_09_554110.jpg Lightly Tariffed AI Hardware Drives Trade Growth and Record US Imports https://kalkine.com/news/general-news/nvidia-nasdaqnvda-seeks-a-new-ceo-as-founder-successions-offer-mixed-lessons Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Nvidia (NASDAQ:NVDA) Seeks a New CEO as Founder Successions Offer Mixed Lessons NASDAQ:NVDA General News https://kalkine.com/featured_image/gallery/large/shutterstock_1403756708_11_13_2026_20_31_18_606528.jpg Nvidia (NASDAQ:NVDA) Seeks a New CEO as Founder Successions Offer Mixed Lessons https://kalkine.com/news/general-news/a-month-of-cyber-incidents-from-php-flaws-to-freezers-tests-defenses Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 A Month of Cyber Incidents, From PHP Flaws to Freezers, Tests Defenses General News https://kalkine.com/featured_image/gallery/large/shutterstock_2348635199_11_13_2026_20_31_04_680431.jpg A Month of Cyber Incidents, From PHP Flaws to Freezers, Tests Defenses https://kalkine.com/news/general-news/heritage-chief-says-republicans-misread-voters-on-data-centers-in-midterms Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Heritage Chief Says Republicans Misread Voters on Data Centers in Midterms General News https://kalkine.com/featured_image/gallery/large/shutterstock_1269571591_11_13_2026_20_31_36_649978.jpg Heritage Chief Says Republicans Misread Voters on Data Centers in Midterms https://kalkine.com/news/general-news/anthropic-listing-tests-an-ai-boom-funded-mostly-by-equity-not-debt Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Anthropic Listing Tests an AI Boom Funded Mostly by Equity, Not Debt General News https://kalkine.com/featured_image/gallery/large/shutterstock_732800311_11_13_2026_20_30_36_691471.jpg Anthropic Listing Tests an AI Boom Funded Mostly by Equity, Not Debt https://kalkine.com/news/general-news/nvidia-ceo-succession-kress-and-jones-take-the-helm Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Nvidia CEO Succession: Kress and Jones Take the Helm General News https://kalkine.com/featured_image/gallery/large/shutterstock_1544161649_11_13_2026_20_32_10_693612.jpg Nvidia CEO Succession: Kress and Jones Take the Helm https://kalkine.com/news/general-news/past-divided-governments-raised-spending-complicating-hopes-of-a-fiscal-brake Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Past Divided Governments Raised Spending, Complicating Hopes of a Fiscal Brake General News https://kalkine.com/featured_image/gallery/large/shutterstock_2183854371_11_13_2026_20_30_59_709524.jpg Past Divided Governments Raised Spending, Complicating Hopes of a Fiscal Brake https://kalkine.com/news/general-news/analysis-puts-ais-2030-revenue-need-at-usd-3-trillion-as-anthropic-lists Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Analysis Puts AI's 2030 Revenue Need at USD 3 Trillion as Anthropic Lists General News https://kalkine.com/featured_image/gallery/large/shutterstock_1786508132_11_13_2026_20_30_40_700817.jpg Analysis Puts AI's 2030 Revenue Need at USD 3 Trillion as Anthropic Lists https://kalkine.com/news/general-news/roche-joins-eli-lilly-in-testing-whether-alzheimers-can-be-prevented-before-symptoms Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Roche Joins Eli Lilly in Testing Whether Alzheimer's Can Be Prevented Before Symptoms General News https://kalkine.com/featured_image/gallery/large/shutterstock_2463472593_11_13_2026_20_31_41_582969.jpg Roche Joins Eli Lilly in Testing Whether Alzheimer's Can Be Prevented Before Symptoms https://kalkine.com/news/general-news/jensen-huang-exit-tests-nvidias-role-as-ais-central-bank Kalkine Equities LLC en 2026-11-15T00:00:00-08:00 Jensen Huang Exit Tests Nvidia’s Role as AI’s Central Bank General News https://kalkine.com/featured_image/gallery/large/shutterstock_2328478655_11_13_2026_20_32_05_836627.jpg Jensen Huang Exit Tests Nvidia’s Role as AI’s Central Bank https://kalkine.com/news/announcements/lilly-presents-eloratzp-and-retatrutide-data-at-obesityweek-2026 Kalkine Equities LLC en 2026-11-14T09:04:50-08:00 Lilly Presents EloraTZP and Retatrutide Data at ObesityWeek 2026 NYSE:LLY Announcements https://kalkine.com/featured_image/gallery/large/announcement2_06_04_2026_07_07_59_200560.webp Lilly Presents EloraTZP and Retatrutide Data at ObesityWeek 2026 https://kalkine.com/news/earnings/american-battery-technology-company-nasdaqabat-stock-fiscal-q1-2027-earnings-revenue-and-black-mass-export-update Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 American Battery Technology Company (NASDAQ:ABAT) Stock: Fiscal Q1 2027 Earnings, Revenue and Black Mass Export Update Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2599174181_11_13_2026_20_25_17_811268.jpg American Battery Technology Company (NASDAQ:ABAT) Stock: Fiscal Q1 2027 Earnings, Revenue and Black Mass Export Update https://kalkine.com/news/earnings/jade-biosciences-nasdaqjbio-stock-q3-2026-earnings-jade101-trial-progress-and-equity-financing-update Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Jade Biosciences (NASDAQ:JBIO) Stock: Q3 2026 Earnings, JADE101 Trial Progress and Equity Financing Update Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_1378539377_11_13_2026_20_26_13_959721.jpg Jade Biosciences (NASDAQ:JBIO) Stock: Q3 2026 Earnings, JADE101 Trial Progress and Equity Financing Update https://kalkine.com/news/earnings/powercompute-nasdaqpwcm-stock-q3-2026-earnings-bitcoin-production-and-debt-repayment-update Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 PowerCompute (NASDAQ:PWCM) Stock: Q3 2026 Earnings, Bitcoin Production and Debt Repayment Update Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2722222155_11_13_2026_20_26_59_992827.jpg PowerCompute (NASDAQ:PWCM) Stock: Q3 2026 Earnings, Bitcoin Production and Debt Repayment Update https://kalkine.com/news/earnings/immunic-nasdaqimux-stock-q3-2026-earnings-nda-readiness-spending-and-stock-compensation-charge Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Immunic (NASDAQ:IMUX) Stock: Q3 2026 Earnings, NDA Readiness Spending and Stock Compensation Charge Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2403370841_11_13_2026_20_26_09_154361.jpg Immunic (NASDAQ:IMUX) Stock: Q3 2026 Earnings, NDA Readiness Spending and Stock Compensation Charge https://kalkine.com/news/earnings/sbc-medical-group-holdings-nasdaqsbc-stock-q3-2026-earnings-revenue-growth-and-cash-position Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 SBC Medical Group Holdings (NASDAQ:SBC) Stock: Q3 2026 Earnings, Revenue Growth and Cash Position Earnings https://kalkine.com/featured_image/gallery/large/F18(5)_11_13_2026_20_27_09_053340.jpg SBC Medical Group Holdings (NASDAQ:SBC) Stock: Q3 2026 Earnings, Revenue Growth and Cash Position https://kalkine.com/news/earnings/pds-biotechnology-nasdaqpdsb-stock-q3-2026-earnings-pipe-financing-and-pds0301-program-update Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 PDS Biotechnology (NASDAQ:PDSB) Stock: Q3 2026 Earnings, PIPE Financing and PDS0301 Program Update Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2449710759_11_13_2026_20_26_55_078434.jpg PDS Biotechnology (NASDAQ:PDSB) Stock: Q3 2026 Earnings, PIPE Financing and PDS0301 Program Update https://kalkine.com/news/earnings/silexion-therapeutics-nasdaqslxn-stock-q3-2026-earnings-sil204-phase-23-trial-start-and-going-concern-disclosure Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Silexion Therapeutics (NASDAQ:SLXN) Stock: Q3 2026 Earnings, SIL204 Phase 2/3 Trial Start and Going Concern Disclosure Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2578983009_11_13_2026_20_27_13_086935.jpg Silexion Therapeutics (NASDAQ:SLXN) Stock: Q3 2026 Earnings, SIL204 Phase 2/3 Trial Start and Going Concern Disclosure https://kalkine.com/news/earnings/suncrete-nasdaqrmix-stock-q3-2026-earnings-ready-mix-revenue-and-revised-2026-outlook Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Suncrete (NASDAQ:RMIX) Stock: Q3 2026 Earnings, Ready-Mix Revenue and Revised 2026 Outlook Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2683868239_11_13_2026_20_27_04_113122.jpg Suncrete (NASDAQ:RMIX) Stock: Q3 2026 Earnings, Ready-Mix Revenue and Revised 2026 Outlook https://kalkine.com/news/earnings/lifeward-nasdaqlfwd-stock-q3-2026-earnings-gross-margin-and-going-concern-disclosure Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Lifeward (NASDAQ:LFWD) Stock: Q3 2026 Earnings, Gross Margin and Going Concern Disclosure Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2171623817_11_13_2026_20_26_18_115687.jpg Lifeward (NASDAQ:LFWD) Stock: Q3 2026 Earnings, Gross Margin and Going Concern Disclosure https://kalkine.com/news/earnings/realloys-nasdaqaloy-stock-q3-2026-earnings-rare-earth-metallization-projects-and-army-lease-term-sheet Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 REalloys (NASDAQ:ALOY) Stock: Q3 2026 Earnings, Rare Earth Metallization Projects and Army Lease Term Sheet Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2490347609_11_13_2026_20_25_27_262205.jpg REalloys (NASDAQ:ALOY) Stock: Q3 2026 Earnings, Rare Earth Metallization Projects and Army Lease Term Sheet https://kalkine.com/news/earnings/cineverse-nasdaqcnvs-stock-fiscal-q2-2027-earnings-advertising-technology-revenue-and-acquisition-integration Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Cineverse (NASDAQ:CNVS) Stock: Fiscal Q2 2027 Earnings, Advertising Technology Revenue and Acquisition Integration Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2613961333_11_13_2026_20_25_55_304212.jpg Cineverse (NASDAQ:CNVS) Stock: Fiscal Q2 2027 Earnings, Advertising Technology Revenue and Acquisition Integration https://kalkine.com/news/earnings/arrive-ai-nasdaqarai-stock-q2-2026-earnings-convertible-note-conversion-loss-and-going-concern-disclosure Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Arrive AI (NASDAQ:ARAI) Stock: Q2 2026 Earnings, Convertible Note Conversion Loss and Going Concern Disclosure Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2625859187_11_13_2026_20_25_36_433876.jpg Arrive AI (NASDAQ:ARAI) Stock: Q2 2026 Earnings, Convertible Note Conversion Loss and Going Concern Disclosure https://kalkine.com/news/earnings/fortress-biotech-nasdaqfbio-stock-q3-2026-earnings-emrosi-sales-and-nine-month-voucher-sale-gain Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Fortress Biotech (NASDAQ:FBIO) Stock: Q3 2026 Earnings, Emrosi Sales and Nine-Month Voucher Sale Gain NASDAQ:MBIO,NASDAQ:DERM Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2468603473_11_13_2026_20_25_59_458470.jpg Fortress Biotech (NASDAQ:FBIO) Stock: Q3 2026 Earnings, Emrosi Sales and Nine-Month Voucher Sale Gain https://kalkine.com/news/earnings/milestone-pharmaceuticals-nasdaqmist-stock-q3-2026-earnings-cardamyst-launch-spending-and-license-revenue Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Milestone Pharmaceuticals (NASDAQ:MIST) Stock: Q3 2026 Earnings, CARDAMYST Launch Spending and License Revenue Earnings https://kalkine.com/featured_image/gallery/large/Superannuation_11_13_2026_20_26_23_501992.jpg Milestone Pharmaceuticals (NASDAQ:MIST) Stock: Q3 2026 Earnings, CARDAMYST Launch Spending and License Revenue https://kalkine.com/news/earnings/american-strategic-investment-nysenyc-stock-q2-2026-earnings-property-defaults-and-disposition-gains Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 American Strategic Investment (NYSE:NYC) Stock: Q2 2026 Earnings, Property Defaults and Disposition Gains Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2319550951_11_13_2026_20_26_41_682413.jpg American Strategic Investment (NYSE:NYC) Stock: Q2 2026 Earnings, Property Defaults and Disposition Gains https://kalkine.com/news/earnings/medicinova-nasdaqmnov-stock-q3-2026-earnings-mn-166-program-spending-and-cash-runway-statement Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 MediciNova (NASDAQ:MNOV) Stock: Q3 2026 Earnings, MN-166 Program Spending and Cash Runway Statement Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_1074715964_11_13_2026_20_26_27_587772.jpg MediciNova (NASDAQ:MNOV) Stock: Q3 2026 Earnings, MN-166 Program Spending and Cash Runway Statement https://kalkine.com/news/earnings/aardvark-therapeutics-nasdaqaard-stock-q3-2026-earnings-ard-101-clinical-hold-lifted-and-cash-position Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Aardvark Therapeutics (NASDAQ:AARD) Stock: Q3 2026 Earnings, ARD-101 Clinical Hold Lifted and Cash Position Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2309802043_11_13_2026_20_25_13_589368.jpg Aardvark Therapeutics (NASDAQ:AARD) Stock: Q3 2026 Earnings, ARD-101 Clinical Hold Lifted and Cash Position https://kalkine.com/news/earnings/metavia-nasdaqmtva-stock-q3-2026-earnings-da-1726-phase-1-spending-and-january-offering Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 MetaVia (NASDAQ:MTVA) Stock: Q3 2026 Earnings, DA-1726 Phase 1 Spending and January Offering Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2603760941_11_13_2026_20_26_32_605803.jpg MetaVia (NASDAQ:MTVA) Stock: Q3 2026 Earnings, DA-1726 Phase 1 Spending and January Offering https://kalkine.com/news/earnings/noodles-company-nasdaqndls-stock-q3-2026-earnings-comparable-sales-and-credit-agreement-amendment Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Noodles & Company (NASDAQ:NDLS) Stock: Q3 2026 Earnings, Comparable Sales and Credit Agreement Amendment Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2520695661_11_13_2026_20_26_36_716682.jpg Noodles & Company (NASDAQ:NDLS) Stock: Q3 2026 Earnings, Comparable Sales and Credit Agreement Amendment https://kalkine.com/news/earnings/bio-key-international-nasdaqbkyi-stock-q3-2026-earnings-license-fee-revenue-and-middle-east-customer-update Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 BIO-key International (NASDAQ:BKYI) Stock: Q3 2026 Earnings, License Fee Revenue and Middle East Customer Update Earnings https://kalkine.com/featured_image/gallery/large/Finanpost_11_13_2026_20_25_45_755817.jpg BIO-key International (NASDAQ:BKYI) Stock: Q3 2026 Earnings, License Fee Revenue and Middle East Customer Update https://kalkine.com/news/earnings/immix-biopharma-nasdaqimmx-stock-q3-2026-earnings-nxc-201-trial-update-and-offering-proceeds Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Immix Biopharma (NASDAQ:IMMX) Stock: Q3 2026 Earnings, NXC-201 Trial Update and Offering Proceeds Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2037364841_11_13_2026_20_26_04_781212.jpg Immix Biopharma (NASDAQ:IMMX) Stock: Q3 2026 Earnings, NXC-201 Trial Update and Offering Proceeds https://kalkine.com/news/earnings/benitec-biopharma-nasdaqbntc-stock-fiscal-q1-2027-earnings-bb-301-trial-progress-and-cash-position Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Benitec Biopharma (NASDAQ:BNTC) Stock: Fiscal Q1 2027 Earnings, BB-301 Trial Progress and Cash Position Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2634082297_11_13_2026_20_25_49_892302.jpg Benitec Biopharma (NASDAQ:BNTC) Stock: Fiscal Q1 2027 Earnings, BB-301 Trial Progress and Cash Position https://kalkine.com/news/earnings/tvardi-therapeutics-nasdaqtvrd-stock-q3-2026-earnings-tti-101-trial-timeline-and-at-the-market-sales Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Tvardi Therapeutics (NASDAQ:TVRD) Stock: Q3 2026 Earnings, TTI-101 Trial Timeline and At-the-Market Sales Earnings https://kalkine.com/featured_image/gallery/large/F3(2)_11_13_2026_20_27_17_786526.jpg Tvardi Therapeutics (NASDAQ:TVRD) Stock: Q3 2026 Earnings, TTI-101 Trial Timeline and At-the-Market Sales https://kalkine.com/news/earnings/owlet-nyseowlt-stock-q3-2026-earnings-subscription-revenue-and-camera-cable-guard-safety-update Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Owlet (NYSE:OWLT) Stock: Q3 2026 Earnings, Subscription Revenue and Camera Cable Guard Safety Update Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_1402124663_11_13_2026_20_26_45_787556.jpg Owlet (NYSE:OWLT) Stock: Q3 2026 Earnings, Subscription Revenue and Camera Cable Guard Safety Update https://kalkine.com/news/earnings/pavmed-nasdaqpavm-stock-q3-2026-earnings-esoguard-medicare-payments-and-veris-update Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 PAVmed (NASDAQ:PAVM) Stock: Q3 2026 Earnings, EsoGuard Medicare Payments and Veris Update NASDAQ:LUCD Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_1962235213_11_13_2026_20_26_50_913599.jpg PAVmed (NASDAQ:PAVM) Stock: Q3 2026 Earnings, EsoGuard Medicare Payments and Veris Update https://kalkine.com/news/earnings/biofrontera-nasdaqbfri-stock-q3-2026-earnings-ameluz-sbcc-approval-and-itc-matter-update Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Biofrontera (NASDAQ:BFRI) Stock: Q3 2026 Earnings, Ameluz sBCC Approval and ITC Matter Update Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2568875199_11_13_2026_20_25_40_769482.jpg Biofrontera (NASDAQ:BFRI) Stock: Q3 2026 Earnings, Ameluz sBCC Approval and ITC Matter Update https://kalkine.com/news/earnings/allarity-therapeutics-nasdaqallr-stock-q3-2026-earnings-stenoparib-phase-3-manufacturing-and-financing-update Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Allarity Therapeutics (NASDAQ:ALLR) Stock: Q3 2026 Earnings, Stenoparib Phase 3 Manufacturing and Financing Update Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_2734139297_11_13_2026_20_25_22_827523.jpg Allarity Therapeutics (NASDAQ:ALLR) Stock: Q3 2026 Earnings, Stenoparib Phase 3 Manufacturing and Financing Update https://kalkine.com/news/earnings/annovis-bio-nyseanvs-stock-preliminary-q3-2026-cash-estimate-ahead-of-quarterly-financial-statements Kalkine Equities LLC en 2026-11-14T00:00:00-08:00 Annovis Bio (NYSE:ANVS) Stock: Preliminary Q3 2026 Cash Estimate Ahead of Quarterly Financial Statements Earnings https://kalkine.com/featured_image/gallery/large/shutterstock_245507587_11_13_2026_20_25_31_832516.jpg Annovis Bio (NYSE:ANVS) Stock: Preliminary Q3 2026 Cash Estimate Ahead of Quarterly Financial Statements https://kalkine.com/news/announcements/dana-incorporated-prices-tender-offers-for-3579m-in-senior-notes Kalkine Equities LLC en 2026-11-13T21:02:21-08:00 Dana Incorporated Prices Tender Offers for $357.9M in Senior Notes NYSE:DAN Announcements https://kalkine.com/featured_image/gallery/large/announcement6_06_04_2026_07_14_09_832695.webp Dana Incorporated Prices Tender Offers for $357.9M in Senior Notes https://kalkine.com/news/announcements/first-horizon-bank-backs-25m-houston-family-opportunity-center Kalkine Equities LLC en 2026-11-13T21:02:08-08:00 First Horizon Bank Backs $25M Houston Family Opportunity Center NYSE:FHN Announcements https://kalkine.com/featured_image/gallery/large/announcement7_06_04_2026_07_12_48_947196.webp First Horizon Bank Backs $25M Houston Family Opportunity Center https://kalkine.com/news/announcements/yiren-digital-receives-nyse-non-compliance-notice-on-ads-price Kalkine Equities LLC en 2026-11-13T21:02:05-08:00 Yiren Digital Receives NYSE Non-Compliance Notice on ADS Price NYSE:YRD Announcements https://kalkine.com/featured_image/gallery/large/announcement2_06_04_2026_07_07_59_200560.webp Yiren Digital Receives NYSE Non-Compliance Notice on ADS Price https://kalkine.com/news/announcements/keycorp-to-redeem-series-e-preferred-stock-dec-15-2026 Kalkine Equities LLC en 2026-11-13T21:02:04-08:00 KeyCorp to Redeem Series E Preferred Stock Dec. 15, 2026 NYSE:KEY Announcements https://kalkine.com/featured_image/gallery/large/announcement6_06_04_2026_07_14_09_832695.webp KeyCorp to Redeem Series E Preferred Stock Dec. 15, 2026 https://kalkine.com/news/announcements/cohen-steers-adds-ahr-gpe-to-realty-index-suite-nov-20 Kalkine Equities LLC en 2026-11-13T21:02:01-08:00 Cohen & Steers Adds AHR, GPE to Realty Index Suite Nov. 20 NYSE:CNS Announcements https://kalkine.com/featured_image/gallery/large/announcement1_06_04_2026_07_06_33_386361.webp Cohen & Steers Adds AHR, GPE to Realty Index Suite Nov. 20